25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Stereotaxis Inc
Buy, Hold or Sell?

Let's analyze Stereotaxis together

I guess you are interested in Stereotaxis Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Stereotaxis Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Stereotaxis Inc

I send you an email if I find something interesting about Stereotaxis Inc.

1. Quick Overview

1.1. Quick analysis of Stereotaxis (30 sec.)










1.2. What can you expect buying and holding a share of Stereotaxis? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
5.0%

What is your share worth?

Current worth
$0.19
Expected worth in 1 year
$0.09
How sure are you?
27.5%

+ What do you gain per year?

Total Gains per Share
$-0.10
Return On Investment
-4.1%

For what price can you sell your share?

Current Price per Share
$2.37
Expected price per share
$1.82 - $2.505
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Stereotaxis (5 min.)




Live pricePrice per Share (EOD)
$2.37
Intrinsic Value Per Share
$-5.71 - $-1.49
Total Value Per Share
$-5.52 - $-1.30

2.2. Growth of Stereotaxis (5 min.)




Is Stereotaxis growing?

Current yearPrevious yearGrowGrow %
How rich?$16.2m$28.1m-$9.3m-50.1%

How much money is Stereotaxis making?

Current yearPrevious yearGrowGrow %
Making money-$5.3m-$4.8m-$534.7k-9.9%
Net Profit Margin-93.2%-66.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Stereotaxis (5 min.)




2.4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#132 / 166

Most Revenue
#130 / 166

Most Profit
#135 / 166

Most Efficient
#140 / 166
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Stereotaxis?

Welcome investor! Stereotaxis's management wants to use your money to grow the business. In return you get a share of Stereotaxis.

First you should know what it really means to hold a share of Stereotaxis. And how you can make/lose money.

Speculation

The Price per Share of Stereotaxis is $2.37. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Stereotaxis.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Stereotaxis, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.19. Based on the TTM, the Book Value Change Per Share is $-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Stereotaxis.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.07-3.0%-0.06-2.7%-0.06-2.6%-0.05-2.0%-0.03-1.4%
Usd Book Value Change Per Share-0.01-0.4%-0.02-1.0%-0.03-1.1%-0.01-0.3%0.010.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.156.4%
Usd Total Gains Per Share-0.01-0.4%-0.02-1.0%-0.03-1.1%-0.01-0.3%0.166.8%
Usd Price Per Share2.04-2.06-1.81-3.61-2.43-
Price to Earnings Ratio-7.07--8.33--7.34--31.08--26.41-
Price-to-Total Gains Ratio-231.07--114.42--73.70--42.37-14.73-
Price to Book Ratio10.79-9.45-5.43-9.37-6.38-
Price-to-Total Gains Ratio-231.07--114.42--73.70--42.37-14.73-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.37
Number of shares421
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.02-0.01
Usd Total Gains Per Share-0.02-0.01
Gains per Quarter (421 shares)-10.29-3.16
Gains per Year (421 shares)-41.15-12.62
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-41-510-13-23
20-82-920-25-36
30-123-1330-38-49
40-165-1740-50-62
50-206-2150-63-75
60-247-2560-76-88
70-288-2970-88-101
80-329-3380-101-114
90-370-3790-114-127
100-412-4200-126-140

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%4.036.00.010.0%6.076.03.07.1%
Book Value Change Per Share0.04.00.00.0%0.012.00.00.0%3.017.00.015.0%11.029.00.027.5%25.059.01.029.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%2.00.038.05.0%3.00.082.03.5%
Total Gains per Share0.04.00.00.0%0.012.00.00.0%3.017.00.015.0%11.029.00.027.5%26.058.01.030.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Stereotaxis Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.009-0.024+177%-0.027+203%-0.007-15%0.009-200%
Book Value Per Share--0.1890.220-14%0.332-43%0.374-49%0.142+33%
Current Ratio--1.3902.151-35%2.831-51%3.193-56%2.170-36%
Debt To Asset Ratio--0.6810.546+25%0.430+58%0.392+74%0.951-28%
Debt To Equity Ratio--2.1401.292+66%0.757+183%0.706+203%0.691+210%
Dividend Per Share----0%-0%-0%0.152-100%
Enterprise Value--151033569.560167296476.070-10%156585004.720-4%316975200.308-52%201728725.297-25%
Eps---0.072-0.063-12%-0.062-13%-0.046-36%-0.033-55%
Ev To Ebitda Ratio---6.443-7.982+24%-7.585+18%-31.799+394%-209.761+3155%
Ev To Sales Ratio--4.1067.136-42%5.382-24%10.889-62%6.810-40%
Free Cash Flow Per Share---0.051-0.036-29%-0.029-42%-0.023-54%-0.139+175%
Free Cash Flow To Equity Per Share---0.050-0.035-29%-0.029-41%-0.012-75%-0.120+143%
Gross Profit Margin--1.5091.574-4%1.658-9%2.140-29%1.382+9%
Intrinsic Value_10Y_max---1.486--------
Intrinsic Value_10Y_min---5.708--------
Intrinsic Value_1Y_max---0.131--------
Intrinsic Value_1Y_min---0.562--------
Intrinsic Value_3Y_max---0.407--------
Intrinsic Value_3Y_min---1.707--------
Intrinsic Value_5Y_max---0.700--------
Intrinsic Value_5Y_min---2.864--------
Market Cap200808924.480+13%175082569.560174677726.070+0%152936754.720+14%305942863.758-43%206133476.397-15%
Net Profit Margin---0.673-0.932+38%-0.660-2%-0.542-19%-0.332-51%
Operating Margin---0.673-0.966+43%-0.736+9%-0.595-12%-0.393-42%
Operating Ratio--1.6901.970-14%1.716-2%1.577+7%1.364+24%
Pb Ratio12.538+14%10.7929.449+14%5.428+99%9.372+15%6.384+69%
Pe Ratio-8.215-16%-7.071-8.326+18%-7.340+4%-31.079+340%-26.413+274%
Price Per Share2.370+14%2.0402.055-1%1.805+13%3.610-43%2.432-16%
Price To Free Cash Flow Ratio-11.720-16%-10.088-15.312+52%-18.503+83%-165.104+1537%-107.586+967%
Price To Total Gains Ratio-268.448-16%-231.069-114.423-50%-73.704-68%-42.368-82%14.726-1669%
Quick Ratio--0.8971.467-39%2.857-69%2.753-67%1.827-51%
Return On Assets---0.122-0.129+7%-0.100-18%-0.075-38%-0.069-43%
Return On Equity---0.382-0.296-22%-0.177-54%-0.139-64%-0.087-77%
Total Gains Per Share---0.009-0.024+177%-0.027+203%-0.007-15%0.161-105%
Usd Book Value--16223000.00018734500.000-13%28122250.000-42%31710196.000-49%12028999.750+35%
Usd Book Value Change Per Share---0.009-0.024+177%-0.027+203%-0.007-15%0.009-200%
Usd Book Value Per Share--0.1890.220-14%0.332-43%0.374-49%0.142+33%
Usd Dividend Per Share----0%-0%-0%0.152-100%
Usd Enterprise Value--151033569.560167296476.070-10%156585004.720-4%316975200.308-52%201728725.297-25%
Usd Eps---0.072-0.063-12%-0.062-13%-0.046-36%-0.033-55%
Usd Free Cash Flow---4339000.000-3058500.000-30%-2496750.000-42%-1993793.900-54%-11774137.450+171%
Usd Free Cash Flow Per Share---0.051-0.036-29%-0.029-42%-0.023-54%-0.139+175%
Usd Free Cash Flow To Equity Per Share---0.050-0.035-29%-0.029-41%-0.012-75%-0.120+143%
Usd Market Cap200808924.480+13%175082569.560174677726.070+0%152936754.720+14%305942863.758-43%206133476.397-15%
Usd Price Per Share2.370+14%2.0402.055-1%1.805+13%3.610-43%2.432-16%
Usd Profit---6190000.000-5392500.000-13%-4857750.000-22%-3670078.850-41%-2361557.500-62%
Usd Revenue--9196000.0006285750.000+46%7376750.000+25%7201985.700+28%7653344.275+20%
Usd Total Gains Per Share---0.009-0.024+177%-0.027+203%-0.007-15%0.161-105%
 EOD+5 -3MRQTTM+13 -25YOY+11 -275Y+3 -3510Y+13 -27

3.3 Fundamental Score

Let's check the fundamental score of Stereotaxis Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-8.215
Price to Book Ratio (EOD)Between0-112.538
Net Profit Margin (MRQ)Greater than0-0.673
Operating Margin (MRQ)Greater than0-0.673
Quick Ratio (MRQ)Greater than10.897
Current Ratio (MRQ)Greater than11.390
Debt to Asset Ratio (MRQ)Less than10.681
Debt to Equity Ratio (MRQ)Less than12.140
Return on Equity (MRQ)Greater than0.15-0.382
Return on Assets (MRQ)Greater than0.05-0.122
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Stereotaxis Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.784
Ma 20Greater thanMa 502.288
Ma 50Greater thanMa 1002.149
Ma 100Greater thanMa 2002.103
OpenGreater thanClose2.330
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Stereotaxis Inc

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Fundamental data was last updated by Penke on 2024-12-19 10:22:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Stereotaxis earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Stereotaxis to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of -67.3% means that $-0.67 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Stereotaxis Inc:

  • The MRQ is -67.3%. The company is making a huge loss. -2
  • The TTM is -93.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-67.3%TTM-93.2%+25.9%
TTM-93.2%YOY-66.0%-27.2%
TTM-93.2%5Y-54.2%-39.0%
5Y-54.2%10Y-33.2%-21.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-67.3%5.2%-72.5%
TTM-93.2%4.7%-97.9%
YOY-66.0%7.8%-73.8%
5Y-54.2%7.4%-61.6%
10Y-33.2%7.7%-40.9%
4.3.1.2. Return on Assets

Shows how efficient Stereotaxis is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Stereotaxis to the Medical Instruments & Supplies industry mean.
  • -12.2% Return on Assets means that Stereotaxis generated $-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Stereotaxis Inc:

  • The MRQ is -12.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -12.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.2%TTM-12.9%+0.8%
TTM-12.9%YOY-10.0%-3.0%
TTM-12.9%5Y-7.5%-5.5%
5Y-7.5%10Y-6.9%-0.5%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.2%1.2%-13.4%
TTM-12.9%1.0%-13.9%
YOY-10.0%1.6%-11.6%
5Y-7.5%2.2%-9.7%
10Y-6.9%2.1%-9.0%
4.3.1.3. Return on Equity

Shows how efficient Stereotaxis is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Stereotaxis to the Medical Instruments & Supplies industry mean.
  • -38.2% Return on Equity means Stereotaxis generated $-0.38 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Stereotaxis Inc:

  • The MRQ is -38.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -29.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-38.2%TTM-29.6%-8.5%
TTM-29.6%YOY-17.7%-11.9%
TTM-29.6%5Y-13.9%-15.7%
5Y-13.9%10Y-8.7%-5.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-38.2%2.4%-40.6%
TTM-29.6%2.0%-31.6%
YOY-17.7%3.4%-21.1%
5Y-13.9%3.7%-17.6%
10Y-8.7%3.7%-12.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Stereotaxis Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Stereotaxis is operating .

  • Measures how much profit Stereotaxis makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Stereotaxis to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of -67.3% means the company generated $-0.67  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Stereotaxis Inc:

  • The MRQ is -67.3%. The company is operating very inefficient. -2
  • The TTM is -96.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-67.3%TTM-96.6%+29.2%
TTM-96.6%YOY-73.6%-22.9%
TTM-96.6%5Y-59.5%-37.1%
5Y-59.5%10Y-39.3%-20.1%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-67.3%8.3%-75.6%
TTM-96.6%7.2%-103.8%
YOY-73.6%9.5%-83.1%
5Y-59.5%9.7%-69.2%
10Y-39.3%10.3%-49.6%
4.3.2.2. Operating Ratio

Measures how efficient Stereotaxis is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 1.69 means that the operating costs are $1.69 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Stereotaxis Inc:

  • The MRQ is 1.690. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.970. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.690TTM1.970-0.280
TTM1.970YOY1.716+0.254
TTM1.9705Y1.577+0.393
5Y1.57710Y1.364+0.213
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6901.047+0.643
TTM1.9701.073+0.897
YOY1.7161.016+0.700
5Y1.5771.047+0.530
10Y1.3641.008+0.356
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Stereotaxis Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Stereotaxis is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 1.39 means the company has $1.39 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Stereotaxis Inc:

  • The MRQ is 1.390. The company is just able to pay all its short-term debts.
  • The TTM is 2.151. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.390TTM2.151-0.761
TTM2.151YOY2.831-0.679
TTM2.1515Y3.193-1.042
5Y3.19310Y2.170+1.023
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3902.062-0.672
TTM2.1512.135+0.016
YOY2.8312.493+0.338
5Y3.1932.639+0.554
10Y2.1702.516-0.346
4.4.3.2. Quick Ratio

Measures if Stereotaxis is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Stereotaxis to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 0.90 means the company can pay off $0.90 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Stereotaxis Inc:

  • The MRQ is 0.897. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.467. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ0.897TTM1.467-0.570
TTM1.467YOY2.857-1.391
TTM1.4675Y2.753-1.287
5Y2.75310Y1.827+0.927
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8971.052-0.155
TTM1.4671.052+0.415
YOY2.8571.190+1.667
5Y2.7531.491+1.262
10Y1.8271.606+0.221
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Stereotaxis Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Stereotaxis assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Stereotaxis to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.68 means that Stereotaxis assets are financed with 68.1% credit (debt) and the remaining percentage (100% - 68.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Stereotaxis Inc:

  • The MRQ is 0.681. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.546. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.681TTM0.546+0.135
TTM0.546YOY0.430+0.116
TTM0.5465Y0.392+0.154
5Y0.39210Y0.951-0.559
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6810.389+0.292
TTM0.5460.369+0.177
YOY0.4300.345+0.085
5Y0.3920.366+0.026
10Y0.9510.376+0.575
4.5.4.2. Debt to Equity Ratio

Measures if Stereotaxis is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Stereotaxis to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 214.0% means that company has $2.14 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Stereotaxis Inc:

  • The MRQ is 2.140. The company is just not able to pay all its debts with equity.
  • The TTM is 1.292. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ2.140TTM1.292+0.847
TTM1.292YOY0.757+0.535
TTM1.2925Y0.706+0.587
5Y0.70610Y0.691+0.014
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1400.566+1.574
TTM1.2920.538+0.754
YOY0.7570.520+0.237
5Y0.7060.626+0.080
10Y0.6910.673+0.018
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Stereotaxis generates.

  • Above 15 is considered overpriced but always compare Stereotaxis to the Medical Instruments & Supplies industry mean.
  • A PE ratio of -7.07 means the investor is paying $-7.07 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Stereotaxis Inc:

  • The EOD is -8.215. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.071. Based on the earnings, the company is expensive. -2
  • The TTM is -8.326. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.215MRQ-7.071-1.144
MRQ-7.071TTM-8.326+1.254
TTM-8.326YOY-7.340-0.986
TTM-8.3265Y-31.079+22.753
5Y-31.07910Y-26.413-4.666
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-8.21517.309-25.524
MRQ-7.07117.309-24.380
TTM-8.32616.899-25.225
YOY-7.34019.331-26.671
5Y-31.07923.636-54.715
10Y-26.41323.601-50.014
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Stereotaxis Inc:

  • The EOD is -11.720. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.088. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -15.312. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-11.720MRQ-10.088-1.632
MRQ-10.088TTM-15.312+5.224
TTM-15.312YOY-18.503+3.191
TTM-15.3125Y-165.104+149.792
5Y-165.10410Y-107.586-57.518
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-11.72010.613-22.333
MRQ-10.08810.816-20.904
TTM-15.3128.398-23.710
YOY-18.5031.392-19.895
5Y-165.1045.020-170.124
10Y-107.586-0.576-107.010
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Stereotaxis is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 10.79 means the investor is paying $10.79 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Stereotaxis Inc:

  • The EOD is 12.538. Based on the equity, the company is expensive. -2
  • The MRQ is 10.792. Based on the equity, the company is expensive. -2
  • The TTM is 9.449. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD12.538MRQ10.792+1.746
MRQ10.792TTM9.449+1.343
TTM9.449YOY5.428+4.021
TTM9.4495Y9.372+0.077
5Y9.37210Y6.384+2.987
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD12.5382.715+9.823
MRQ10.7922.649+8.143
TTM9.4492.709+6.740
YOY5.4282.728+2.700
5Y9.3723.663+5.709
10Y6.3844.369+2.015
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Stereotaxis Inc.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets50,935
Total Liabilities34,712
Total Stockholder Equity16,223
 As reported
Total Liabilities 34,712
Total Stockholder Equity+ 16,223
Total Assets = 50,935

Assets

Total Assets50,935
Total Current Assets28,812
Long-term Assets22,123
Total Current Assets
Cash And Cash Equivalents 10,663
Net Receivables 7,921
Inventory 9,009
Other Current Assets 1,219
Total Current Assets  (as reported)28,812
Total Current Assets  (calculated)28,812
+/-0
Long-term Assets
Property Plant Equipment 9,351
Goodwill 4,494
Intangible Assets 8,162
Long-term Assets Other 116
Long-term Assets  (as reported)22,123
Long-term Assets  (calculated)22,123
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities20,721
Long-term Liabilities13,991
Total Stockholder Equity16,223
Total Current Liabilities
Short-term Debt 552
Accounts payable 6,403
Other Current Liabilities 8,674
Total Current Liabilities  (as reported)20,721
Total Current Liabilities  (calculated)15,629
+/- 5,092
Long-term Liabilities
Capital Lease Obligations 6,135
Long-term Liabilities Other 6,251
Long-term Liabilities  (as reported)13,991
Long-term Liabilities  (calculated)12,386
+/- 1,605
Total Stockholder Equity
Common Stock85
Retained Earnings -554,210
Other Stockholders Equity 564,940
Total Stockholder Equity (as reported)16,223
Total Stockholder Equity (calculated)10,815
+/- 5,408
Other
Capital Stock5,493
Cash and Short Term Investments 10,663
Common Stock Shares Outstanding 85,825
Current Deferred Revenue5,092
Liabilities and Stockholders Equity 50,935
Net Debt -4,528
Net Invested Capital 10,815
Net Working Capital 8,091
Property Plant and Equipment Gross 13,643
Short Long Term Debt Total 6,135



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-06-302002-12-31
> Total Assets 
32,921
0
37,323
47,162
41,057
77,668
71,188
63,972
58,038
46,376
36,658
84,095
72,896
70,695
69,291
80,566
67,601
61,951
60,476
49,036
50,139
55,076
59,440
53,224
43,910
40,483
56,121
49,978
50,863
47,514
65,762
60,549
49,283
36,871
39,932
36,792
36,616
35,173
32,166
32,166
23,995
26,367
31,076
29,838
27,286
26,157
23,881
22,032
19,945
18,637
19,227
15,186
16,259
21,598
20,966
18,989
16,684
15,126
10,667
21,327
19,969
19,621
18,515
22,443
21,255
43,306
43,585
41,503
57,050
57,132
55,456
58,818
57,336
61,920
60,985
57,429
56,678
56,075
53,413
50,711
48,315
44,528
41,909
39,452
36,014
50,935
50,93536,01439,45241,90944,52848,31550,71153,41356,07556,67857,42960,98561,92057,33658,81855,45657,13257,05041,50343,58543,30621,25522,44318,51519,62119,96921,32710,66715,12616,68418,98920,96621,59816,25915,18619,22718,63719,94522,03223,88126,15727,28629,83831,07626,36723,99532,16632,16635,17336,61636,79239,93236,87149,28360,54965,76247,51450,86349,97856,12140,48343,91053,22459,44055,07650,13949,03660,47661,95167,60180,56669,29170,69572,89684,09536,65846,37658,03863,97271,18877,66841,05747,16237,323032,921
   > Total Current Assets 
0
0
0
0
36,567
71,931
61,464
54,175
52,315
42,223
31,628
78,436
66,770
64,493
63,294
72,942
59,124
52,821
50,936
39,354
40,878
46,468
51,345
44,641
36,572
34,030
50,042
44,149
43,523
40,610
59,194
54,075
43,004
30,759
34,236
31,454
31,653
30,587
27,939
27,939
20,475
23,139
28,158
27,151
24,734
23,774
21,218
19,498
17,317
16,110
17,260
13,598
14,820
20,302
19,404
17,626
15,514
14,068
9,871
20,440
19,214
18,832
17,973
16,363
15,544
38,050
38,830
37,200
53,235
53,877
54,952
56,541
55,235
53,411
51,388
47,134
46,641
46,079
43,246
40,905
38,902
35,514
33,167
31,108
28,072
28,812
28,81228,07231,10833,16735,51438,90240,90543,24646,07946,64147,13451,38853,41155,23556,54154,95253,87753,23537,20038,83038,05015,54416,36317,97318,83219,21420,4409,87114,06815,51417,62619,40420,30214,82013,59817,26016,11017,31719,49821,21823,77424,73427,15128,15823,13920,47527,93927,93930,58731,65331,45434,23630,75943,00454,07559,19440,61043,52344,14950,04234,03036,57244,64151,34546,46840,87839,35450,93652,82159,12472,94263,29464,49366,77078,43631,62842,22352,31554,17561,46471,93136,5670000
       Cash And Cash Equivalents 
0
0
0
0
21,221
47,777
16,908
25,929
15,501
6,391
5,211
44,451
31,142
22,629
15,210
46,444
26,058
26,433
17,022
10,973
11,358
19,785
30,356
18,800
12,780
12,013
30,547
24,513
22,014
21,793
35,249
30,395
23,260
16,980
13,955
10,469
12,119
9,913
7,778
7,778
4,114
8,387
13,775
11,302
10,598
8,724
7,270
4,439
3,629
3,618
5,594
1,603
3,858
9,245
8,501
5,739
5,035
4,487
3,686
11,614
11,992
11,571
10,796
9,041
8,472
31,651
30,182
28,025
44,006
43,596
43,940
42,453
42,054
40,243
38,739
35,095
33,498
30,938
8,586
5,623
22,877
22,100
20,343
18,158
14,683
10,663
10,66314,68318,15820,34322,10022,8775,6238,58630,93833,49835,09538,73940,24342,05442,45343,94043,59644,00628,02530,18231,6518,4729,04110,79611,57111,99211,6143,6864,4875,0355,7398,5019,2453,8581,6035,5943,6183,6294,4397,2708,72410,59811,30213,7758,3874,1147,7787,7789,91312,11910,46913,95516,98023,26030,39535,24921,79322,01424,51330,54712,01312,78018,80030,35619,78511,35810,97317,02226,43326,05846,44415,21022,62931,14244,4515,2116,39115,50125,92916,90847,77721,2210000
       Short-term Investments 
0
0
0
0
4,977
10,074
28,741
12,410
18,311
15,867
5,525
13,498
13,575
17,187
21,773
2,993
6,761
2,128
6,634
6,634
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,041
799
824
0
600
650
423
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,844
20,041
0
0
0
0
0
0
00000020,04119,8440000000000000000000000000000000042365060008247991,04100000000000000000006,6346,6342,1286,7612,99321,77317,18713,57513,4985,52515,86718,31112,41028,74110,0744,9770000
       Net Receivables 
0
0
0
0
3,483
7,611
8,790
8,883
10,959
9,389
6,359
5,379
7,700
13,109
15,444
11,850
15,365
12,478
13,894
12,715
15,001
13,316
9,936
12,761
12,149
11,888
11,219
10,648
14,212
10,974
13,946
13,247
10,243
4,598
11,164
10,353
8,296
10,571
11,570
11,570
8,486
8,096
7,558
8,347
6,456
7,028
6,480
7,737
7,450
6,599
6,376
6,398
5,058
4,882
4,666
5,317
4,877
4,048
4,287
6,638
4,793
5,088
5,021
5,239
4,997
3,830
5,330
4,615
3,041
5,410
3,515
7,291
4,652
5,073
5,406
4,693
3,748
5,077
5,090
4,874
6,645
5,246
3,822
3,953
2,782
7,921
7,9212,7823,9533,8225,2466,6454,8745,0905,0773,7484,6935,4065,0734,6527,2913,5155,4103,0414,6155,3303,8304,9975,2395,0215,0884,7936,6384,2874,0484,8775,3174,6664,8825,0586,3986,3766,5997,4507,7376,4807,0286,4568,3477,5588,0968,48611,57011,57010,5718,29610,35311,1644,59810,24313,24713,94610,97414,21210,64811,21911,88812,14912,7619,93613,31615,00112,71513,89412,47815,36511,85015,44413,1097,7005,3796,3599,38910,9598,8838,7907,6113,4830000
       Other Current Assets 
470
0
876
1,108
2,662
2,348
2,351
1,938
2,280
2,988
5,129
4,259
1,407
2,523
2,581
1,635
2,249
3,002
3,421
5,128
4,893
5,008
1,727
4,935
4,184
3,149
3,873
4,048
3,025
2,585
4,558
4,390
3,586
3,315
3,081
3,417
3,859
3,374
3,492
3,492
2,295
842
1,945
1,929
1,624
17
1,095
947
739
761
785
1,151
570
774
855
912
617
927
750
742
884
970
964
774
514
1,022
1,471
1,391
1,612
337
4,202
1,925
2,898
355
2,356
101
991
1,285
1,325
1,332
1,108
855
576
2,215
1,323
1,219
1,2191,3232,2155768551,1081,3321,3251,2859911012,3563552,8981,9254,2023371,6121,3911,4711,0225147749649708847427509276179128557745701,1517857617399471,095171,6241,9291,9458422,2953,4923,4923,3743,8593,4173,0813,3153,5864,3904,5582,5853,0254,0483,8733,1494,1844,9351,7275,0084,8935,1283,4213,0022,2491,6352,5812,5231,4074,2595,1292,9882,2801,9382,3512,3482,6621,1088760470
   > Long-term Assets 
0
0
0
0
4,490
5,737
9,724
9,797
5,723
4,153
5,030
5,659
6,126
6,202
5,996
7,624
8,477
9,130
9,540
9,682
9,261
8,607
8,095
8,583
7,338
6,454
6,078
5,829
7,340
6,904
6,567
6,474
6,278
6,112
5,696
5,339
4,963
4,586
4,227
4,227
3,521
3,228
2,919
2,687
2,552
2,384
2,663
2,534
2,628
2,526
1,967
1,588
1,439
1,296
1,562
1,363
1,170
1,058
797
887
755
790
542
6,079
5,711
5,256
4,755
4,303
3,815
3,256
504
2,276
2,101
8,510
9,596
10,295
10,037
9,996
10,167
9,806
9,413
9,014
8,742
8,344
7,942
22,123
22,1237,9428,3448,7429,0149,4139,80610,1679,99610,03710,2959,5968,5102,1012,2765043,2563,8154,3034,7555,2565,7116,0795427907558877971,0581,1701,3631,5621,2961,4391,5881,9672,5262,6282,5342,6632,3842,5522,6872,9193,2283,5214,2274,2274,5864,9635,3395,6966,1126,2786,4746,5676,9047,3405,8296,0786,4547,3388,5838,0958,6079,2619,6829,5409,1308,4777,6245,9966,2026,1265,6595,0304,1535,7239,7979,7245,7374,4900000
       Property Plant Equipment 
700
0
2,310
2,511
2,178
1,587
1,558
1,619
1,666
1,856
3,078
3,889
4,392
4,300
4,130
5,396
6,298
6,964
7,012
6,608
6,359
5,858
6,421
6,955
5,819
5,106
4,790
4,585
4,445
4,108
3,841
3,815
3,725
3,634
3,324
3,062
2,764
2,460
2,142
2,142
1,639
1,419
1,185
1,048
988
897
895
877
1,077
1,077
1,067
970
858
767
1,086
935
792
725
593
462
366
453
344
5,909
5,543
5,042
4,537
4,010
3,546
2,999
195
1,898
1,435
7,556
8,367
8,904
8,813
8,888
9,215
9,010
8,778
8,529
8,286
8,040
7,826
9,351
9,3517,8268,0408,2868,5298,7789,0109,2158,8888,8138,9048,3677,5561,4351,8981952,9993,5464,0104,5375,0425,5435,9093444533664625937257929351,0867678589701,0671,0771,0778778958979881,0481,1851,4191,6392,1422,1422,4602,7643,0623,3243,6343,7253,8153,8414,1084,4454,5854,7905,1065,8196,9556,4215,8586,3596,6087,0126,9646,2985,3964,1304,3004,3923,8893,0781,8561,6661,6191,5581,5872,1782,5112,3100700
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1,977,341
-1,827,574
0
0
0
0
-1,453,156
0
0
0
0
0
0
0
0
0
0
0
0
0
-142,830
0
-109,869
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,494
4,49400000000000000000000000-109,8690-142,8300000000000000-1,453,1560000-1,827,574-1,977,341000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
80
82
52
31
32
33
73
19
20
20
20
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
95
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000095000000000000000000000000202020197333323152828000000000000000000000000000000000
       Intangible Assets 
0
0
1,944
1,911
1,878
1,844
1,811
1,778
1,744
1,711
1,678
1,644
1,611
1,578
1,544
1,511
1,478
1,444
1,411
1,378
1,344
1,311
1,278
1,244
1,211
1,178
1,144
1,111
2,743
2,654
2,579
2,504
2,429
2,354
2,279
2,204
2,129
2,054
1,979
1,979,320
1,829,403
1,754
1,679
1,605
1,530
1,454,611
1,380
1,305
1,230
1,155
636
586
536
486
437
387
337
287
159
142,973
126
109,979
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,162
8,16200000000000000000000000109,979126142,9731592873373874374865365866361,1551,2301,3051,3801,454,6111,5301,6051,6791,7541,829,4031,979,3201,9792,0542,1292,2042,2792,3542,4292,5042,5792,6542,7431,1111,1441,1781,2111,2441,2781,3111,3441,3781,4111,4441,4781,5111,5441,5781,6111,6441,6781,7111,7441,7781,8111,8441,8781,9111,94400
       Long-term Assets Other 
0
0
0
0
434
2,305
6,355
6,401
2,312
586
274
126
123
324
322
717
702
721
1,117
1,697
1,558
1,439
397
383
309
170
144
133
152
142
148
155
124
123
93
73
70
72
33
106
52
54
55
34
34
32
389
353
321
295
264
32
45
43
39
41
41
46
44
282
262
227
198
170
168
214
218
292
270
257
309
285
283
253
278
253
218
233
208
184
154
135
237
216
116
116
116116216237135154184208233218253278253283285309257270292218214168170198227262282444641413943453226429532135338932343455545210633727073931231241551481421521331441703093833971,4391,5581,6971,1177217027173223241231262745862,3126,4016,3552,3054340000
> Total Liabilities 
8,914
0
12,057
13,616
15,611
13,778
12,793
12,376
17,573
17,146
18,532
17,088
17,878
21,841
24,502
24,400
24,634
27,500
36,281
34,635
47,073
60,334
54,670
57,706
54,413
55,750
48,479
49,330
51,702
52,833
55,287
58,714
56,318
50,961
58,761
60,161
50,094
50,428
50,956
50,956
49,633
44,167
42,778
45,429
41,988
39,962
36,430
36,813
35,837
35,217
36,853
34,808
37,928
43,061
36,495
33,089
30,782
33,334
31,274
13,045
12,280
11,887
11,243
17,114
16,597
14,588
15,060
14,219
15,687
16,514
15,227
18,468
15,291
21,763
21,561
19,523
21,152
22,724
21,484
21,418
21,346
20,230
19,989
19,421
19,250
34,712
34,71219,25019,42119,98920,23021,34621,41821,48422,72421,15219,52321,56121,76315,29118,46815,22716,51415,68714,21915,06014,58816,59717,11411,24311,88712,28013,04531,27433,33430,78233,08936,49543,06137,92834,80836,85335,21735,83736,81336,43039,96241,98845,42942,77844,16749,63350,95650,95650,42850,09460,16158,76150,96156,31858,71455,28752,83351,70249,33048,47955,75054,41357,70654,67060,33447,07334,63536,28127,50024,63424,40024,50221,84117,87817,08818,53217,14617,57312,37612,79313,77815,61113,61612,05708,914
   > Total Current Liabilities 
6,618
0
9,737
11,326
10,785
12,586
11,792
10,697
15,951
15,764
15,731
14,212
15,385
19,613
22,911
22,620
21,682
24,429
29,010
32,191
38,990
43,598
28,014
41,164
39,946
32,665
27,164
40,000
43,744
46,830
46,799
51,299
49,916
50,623
40,832
46,836
34,089
32,502
33,654
33,654
31,489
25,631
23,806
26,494
23,079
20,553
16,651
17,191
16,666
16,115
16,139
14,677
18,922
42,050
35,653
32,333
30,084
32,120
30,127
11,903
11,222
10,763
10,194
12,463
12,779
11,192
12,161
11,867
13,854
13,447
13,573
16,686
13,436
13,842
13,262
11,491
13,657
15,554
14,291
14,269
14,382
13,032
13,247
12,852
12,252
20,721
20,72112,25212,85213,24713,03214,38214,26914,29115,55413,65711,49113,26213,84213,43616,68613,57313,44713,85411,86712,16111,19212,77912,46310,19410,76311,22211,90330,12732,12030,08432,33335,65342,05018,92214,67716,13916,11516,66617,19116,65120,55323,07926,49423,80625,63131,48933,65433,65432,50234,08946,83640,83250,62349,91651,29946,79946,83043,74440,00027,16432,66539,94641,16428,01443,59838,99032,19129,01024,42921,68222,62022,91119,61315,38514,21215,73115,76415,95110,69711,79212,58610,78511,3269,73706,618
       Short-term Debt 
0
0
0
0
1,385
1,184
910
822
730
667
1,000
1,000
1,000
833
1,667
1,500
1,000
1,000
972
5,889
14,040
17,957
3,901
13,901
14,901
8,735
3,333
14,167
19,500
20,969
20,894
26,500
24,533
28,992
21,173
26,731
13,891
13,680
12,264
12,264
12,061
3,243
50
7,804
6,292
6,527
5,505
5,242
6,003
6,043
6,058
5,245
3,000
5,224
4,491
4,086
3,888
3,512
3,195
0
0
0
0
2,160
2,223
2,235
2,248
2,256
4,424
2,733
3,473
3,649
1,169
655
268
297
328
359
373
385
399
413
428
886
916
552
5529168864284133993853733593282972686551,1693,6493,4732,7334,4242,2562,2482,2352,2232,16000003,1953,5123,8884,0864,4915,2243,0005,2456,0586,0436,0035,2425,5056,5276,2927,804503,24312,06112,26412,26413,68013,89126,73121,17328,99224,53326,50020,89420,96919,50014,1673,3338,73514,90113,9013,90117,95714,0405,8899721,0001,0001,5001,6678331,0001,0001,0006677308229101,1841,3850000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,160
0
0
0
0
2,158
457
1,185
1,915
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000001,9151,1854572,15800002,160000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
1,505
0
1,697
1,878
2,557
2,586
2,129
2,061
6,518
4,376
4,866
4,183
4,032
3,857
5,555
5,030
5,412
6,117
7,349
7,125
5,247
4,513
4,562
5,331
4,280
4,084
3,881
5,038
5,767
6,755
8,796
7,365
7,930
7,006
5,610
6,003
4,636
4,577
8,918
3,557
3,945
3,194
3,512
3,155
3,155
2,505
2,353
2,604
2,293
2,323
1,840
2,042
2,428
2,859
2,623
2,215
1,737
1,733
1,654
1,819
1,353
1,574
1,726
2,383
1,642
1,032
2,099
2,002
1,572
1,569
1,609
2,270
1,124
3,937
4,188
2,892
4,244
3,941
3,270
3,535
2,840
3,243
3,190
3,307
4,146
6,403
6,4034,1463,3073,1903,2432,8403,5353,2703,9414,2442,8924,1883,9371,1242,2701,6091,5691,5722,0022,0991,0321,6422,3831,7261,5741,3531,8191,6541,7331,7372,2152,6232,8592,4282,0421,8402,3232,2932,6042,3532,5053,1553,1553,5123,1943,9453,5578,9184,5774,6366,0035,6107,0067,9307,3658,7966,7555,7675,0383,8814,0844,2805,3314,5624,5135,2477,1257,3496,1175,4125,0305,5553,8574,0324,1834,8664,3766,5182,0612,1292,5862,5571,8781,69701,505
       Other Current Liabilities 
4,209
0
5,751
7,316
4,834
6,070
5,710
5,658
7,043
7,706
5,649
4,818
5,747
7,661
10,025
11,030
8,208
11,336
11,913
9,045
8,540
7,556
9,874
13,513
12,656
12,950
12,758
12,676
10,871
11,934
10,508
11,181
10,753
6,443
5,829
5,824
8,027
6,794
12,471
8,330
7,106
11,795
12,724
6,721
5,540
3,505
2,134
3,027
2,027
1,302
794
763
6,059
27,522
19,787
16,658
16,357
20,816
19,575
2,948
2,959
2,823
2,642
2,274
2,376
2,641
2,721
2,342
2,402
2,956
3,209
2,578
2,857
2,562
2,528
1,967
2,126
3,211
3,306
2,804
2,920
3,160
2,972
2,721
2,240
8,674
8,6742,2402,7212,9723,1602,9202,8043,3063,2112,1261,9672,5282,5622,8572,5783,2092,9562,4022,3422,7212,6412,3762,2742,6422,8232,9592,94819,57520,81616,35716,65819,78727,5226,0597637941,3022,0273,0272,1343,5055,5406,72112,72411,7957,1068,33012,4716,7948,0275,8245,8296,44310,75311,18110,50811,93410,87112,67612,75812,95012,65613,5139,8747,5568,5409,04511,91311,3368,20811,03010,0257,6615,7474,8185,6497,7067,0435,6585,7106,0704,8347,3165,75104,209
   > Long-term Liabilities 
0
0
0
0
4,826
1,192
1,001
1,679
1,622
1,382
2,801
2,876
2,493
2,229
1,591
1,781
2,953
3,072
7,271
2,444
8,082
16,736
26,656
16,542
14,467
23,085
21,315
9,329
7,958
6,003
8,488
7,415
6,402
338
17,928
13,325
16,005
17,926
17,302
17,302
18,144
18,535
18,973
18,934
18,909
19,410
19,780
19,622
19,171
19,101
20,714
20,131
19,006
1,011
843
756
698
1,215
1,147
1,142
1,058
1,124
1,049
4,652
3,818
3,396
2,899
2,352
1,833
3,067
1,653
1,782
1,855
7,921
8,299
8,032
7,495
7,170
7,193
7,149
6,964
7,198
6,742
6,569
6,998
13,991
13,9916,9986,5696,7427,1986,9647,1497,1937,1707,4958,0328,2997,9211,8551,7821,6533,0671,8332,3522,8993,3963,8184,6521,0491,1241,0581,1421,1471,2156987568431,01119,00620,13120,71419,10119,17119,62219,78019,41018,90918,93418,97318,53518,14417,30217,30217,92616,00513,32517,9283386,4027,4158,4886,0037,9589,32921,31523,08514,46716,54226,65616,7368,0822,4447,2713,0722,9531,7811,5912,2292,4932,8762,8011,3821,6221,6791,0011,1924,8260000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,000
0
17,291
12,721
15,238
17,183
16,825
20,176
17,809
18,242
18,481
18,493
18,507
18,436
18,389
18,320
18,308
18,283
18,429
18,078
18,114
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,701
973
244
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000002449731,701000000000000000018,11418,07818,42918,28318,30818,32018,38918,43618,50718,49318,48118,24217,80920,17616,82517,18315,23812,72117,29106,00000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
-1,385
-1,184
-910
-822
-730
-667
-1,000
-1,000
-1,000
-833
-1,667
-1,500
-1,000
-1,000
-972
-5,889
-14,040
-17,957
-3,901
-13,901
-14,901
-8,735
-3,333
-14,167
-19,500
-20,969
-20,894
-26,500
-24,533
-28,992
-21,173
-26,731
-13,891
-13,680
-12,264
-12,264
-12,061
-3,243
-50
-7,804
-6,292
-6,527
-5,505
-5,242
-6,003
-6,043
-6,058
-5,245
-3,000
-5,224
-4,491
-4,086
-3,888
-3,512
-3,195
0
0
0
0
3,433
3,049
2,574
2,090
1,586
-1,089
83
-1,185
-1,915
0
5,912
5,842
5,754
5,663
5,586
5,488
5,387
5,282
5,173
5,062
4,502
4,365
5,583
5,5834,3654,5025,0625,1735,2825,3875,4885,5865,6635,7545,8425,9120-1,915-1,18583-1,0891,5862,0902,5743,0493,4330000-3,195-3,512-3,888-4,086-4,491-5,224-3,000-5,245-6,058-6,043-6,003-5,242-5,505-6,527-6,292-7,804-50-3,243-12,061-12,264-12,264-13,680-13,891-26,731-21,173-28,992-24,533-26,500-20,894-20,969-19,500-14,167-3,333-8,735-14,901-13,901-3,901-17,957-14,040-5,889-972-1,000-1,000-1,500-1,667-833-1,000-1,000-1,000-667-730-822-910-1,184-1,3850000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,960
5,960
5,960
5,960
5,960
5,960
5,960
5,960
5,960
5,955
5,949
5,930
5,758
5,709
5,682
5,605
5,605
5,578
5,578
5,584
5,584
5,584
5,584
5,584
5,583
5,583
5,583
0
0
0
0
0
000005,5835,5835,5835,5845,5845,5845,5845,5845,5785,5785,6055,6055,6825,7095,7585,9305,9495,9555,9605,9605,9605,9605,9605,9605,9605,9605,960000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
3
3
2
1
0
0
0
0
0
0
0
0
0
415
339
6
6
276
270
270
388
320
321
321
497
535
581
534
1,124
1,049
4,652
3,818
3,396
2,899
2,352
1,833
1,366
680
1,538
207
7,921
8,299
8,032
7,495
168
51
7,149
6,964
43
43
0
0
6,251
6,2510043436,9647,149511687,4958,0328,2997,9212071,5386801,3661,8332,3522,8993,3963,8184,6521,0491,124534581535497321321320388270270276663394150000000001233400000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
398
335
635
603
767
743
477
360
335
293
491
442
402
974
976
963
857
812
2,009
1,782
621
623
522
436
377
717
612
561
524
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000005245616127173774365226236211,7822,00981285796397697440244249129333536047774376760363533539800000000000000000000000000000000
> Total Stockholder Equity
24,007
0
25,266
33,546
25,446
63,890
58,394
51,596
40,465
29,230
18,126
67,007
55,018
48,854
44,789
56,166
42,967
34,451
24,194
14,400
3,067
-5,259
4,771
-4,481
-10,503
-15,266
7,641
648
-839
-5,319
10,475
1,835
-7,035
-14,090
-18,829
-23,369
-13,478
-15,254
-18,790
-18,790
-25,637
-17,800
-11,702
-15,590
-14,701
-13,805
-12,550
-14,781
-15,891
-16,580
-17,626
-19,622
-21,669
-21,463
-15,529
-14,100
-14,098
-18,209
-20,607
8,283
7,689
7,734
7,272
5,328
4,658
28,718
28,525
27,284
41,363
40,618
40,229
40,349
42,045
40,157
39,424
37,906
35,526
33,351
31,929
29,293
26,969
24,298
21,920
20,031
16,764
16,223
16,22316,76420,03121,92024,29826,96929,29331,92933,35135,52637,90639,42440,15742,04540,34940,22940,61841,36327,28428,52528,7184,6585,3287,2727,7347,6898,283-20,607-18,209-14,098-14,100-15,529-21,463-21,669-19,622-17,626-16,580-15,891-14,781-12,550-13,805-14,701-15,590-11,702-17,800-25,637-18,790-18,790-15,254-13,478-23,369-18,829-14,090-7,0351,83510,475-5,319-8396487,641-15,266-10,503-4,4814,771-5,2593,06714,40024,19434,45142,96756,16644,78948,85455,01867,00718,12629,23040,46551,59658,39463,89025,44633,54625,266024,007
   Common Stock
1
0
2
0
2
27
27
27
28
28
28
34
34
35
35
37
37
37
37
37
37
37
42
42
43
43
50
50
50
50
55
55
55
55
55
56
8
8
8
8
8
16
19
19
20
20
20
21
21
21
22
22
22
22
22
23
23
23
23
59
59
59
59
59
59
67
69
69
73
74
74
74
74
75
75
75
75
75
75
75
81
81
81
82
83
85
858382818181757575757575757474747473696967595959595959232323232222222222212121202020191916888885655555555555050505043434242373737373737373535343428282827272720201
   Retained Earnings Total Equity00000-527,271-522,314-516,967-512,814-507,896-502,762-498,675-495,321-490,702-489,492-487,959-486,778-485,205-483,284-481,313-480,228-480,272-478,844-476,721-476,152-476,035-475,403-477,133-474,580-470,246-470,068-471,245-476,779-470,566-468,233-465,959-464,277-463,280-461,741-458,606-459,462-459,485-457,543-453,403-449,441-392,573-389,566-384,646-380,329-378,414-381,220-375,407-369,894-362,62100000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
-1,016
-877
-941
-664
-2,992
-2,576
-2,795
-206
-32
1
2
0
0
-1
2
-4,969
-5,529
-5,990
-6,550
-7,012
-6,504
-6,420
-6,616
-7,110
-7,516
-7,812
-8,131
-8,484
-8,856
-9,208
-8,675
-8,977
-9,205
-9,281
-9,252
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-6,137
-5,960
-5,960
-5,960
-5,960
-5,960
-5,960
-5,960
-5,960
-5,960
-5,955
-5,949
-5,935
-5,764
-5,715
-5,688
-5,611
-5,611
-5,584
-5,584
-5,589
0
0
0
0
0
0
526,605
533,593
-81
-5,464
-83
0
0-83-5,464-81533,593526,605000000-5,589-5,584-5,584-5,611-5,611-5,688-5,715-5,764-5,935-5,949-5,955-5,960-5,960-5,960-5,960-5,960-5,960-5,960-5,960-5,960-6,13700000000000000-9,252-9,281-9,205-8,977-8,675-9,208-8,856-8,484-8,131-7,812-7,516-7,110-6,616-6,420-6,504-7,012-6,550-5,990-5,529-4,9692-10021-32-206-2,795-2,576-2,992-664-941-877-1,0160000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
355,737
355,955
356,729
358,001
365,134
365,273
366,054
367,048
367,133
431,832
441,888
442,140
444,969
445,842
446,242
447,146
447,574
447,882
448,517
448,795
449,081
449,363
449,939
450,191
450,370
450,594
450,748
477,872
477,911
478,072
478,180
478,364
479,127
503,150
504,211
504,990
521,014
521,918
522,710
524,389
527,294
530,020
532,641
535,209
537,963
540,706
543,438
546,149
548,782
0
0
0
0
0
00000548,782546,149543,438540,706537,963535,209532,641530,020527,294524,389522,710521,918521,014504,990504,211503,150479,127478,364478,180478,072477,911477,872450,748450,594450,370450,191449,939449,363449,081448,795448,517447,882447,574447,146446,242445,842444,969442,140441,888431,832367,133367,048366,054365,273365,134358,001356,729355,955355,73700000000000000000000000000000000
   Treasury Stock000000000000000000000000-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-206-193-163-163-163-163-163-163-180-180-2
   Other Stockholders Equity 
0
0
0
0
130,025
173,689
173,981
174,245
176,775
177,030
179,124
240,006
241,453
246,609
248,703
270,583
272,390
274,273
276,228
279,967
281,422
283,170
300,687
298,965
300,383
301,433
331,044
332,477
334,852
335,516
353,797
354,706
355,531
355,749
356,523
357,795
364,928
365,067
0
365,848
366,927
431,626
441,682
441,934
444,763
445,636
446,036
446,940
447,368
447,676
448,311
448,589
448,875
455,295
455,694
455,946
456,125
456,349
456,503
483,627
483,665
483,826
483,934
484,113
484,870
508,879
509,769
510,499
526,495
527,323
528,115
529,767
532,672
535,403
532,435
535,003
537,757
540,500
543,232
545,943
21,971
17,681
554,023
556,672
559,293
564,940
564,940559,293556,672554,02317,68121,971545,943543,232540,500537,757535,003532,435535,403532,672529,767528,115527,323526,495510,499509,769508,879484,870484,113483,934483,826483,665483,627456,503456,349456,125455,946455,694455,295448,875448,589448,311447,676447,368446,940446,036445,636444,763441,934441,682431,626366,927365,8480365,067364,928357,795356,523355,749355,531354,706353,797335,516334,852332,477331,044301,433300,383298,965300,687283,170281,422279,967276,228274,273272,390270,583248,703246,609241,453240,006179,124177,030176,775174,245173,981173,689130,0250000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue26,771
Cost of Revenue-11,911
Gross Profit14,86014,860
 
Operating Income (+$)
Gross Profit14,860
Operating Expense-36,699
Operating Income-21,839-21,839
 
Operating Expense (+$)
Research Development10,273
Selling General Administrative14,050
Selling And Marketing Expenses12,376
Operating Expense36,69936,699
 
Net Interest Income (+$)
Interest Income1,096
Interest Expense-0
Other Finance Cost-41
Net Interest Income1,137
 
Pretax Income (+$)
Operating Income-21,839
Net Interest Income1,137
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-20,713-22,965
EBIT - interestExpense = -21,839
-20,286
-20,713
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-21,839-20,713
Earnings Before Interest and Taxes (EBITDA)-21,244
 
After tax Income (+$)
Income Before Tax-20,713
Tax Provision-0
Net Income From Continuing Ops-19,827-20,713
Net Income-20,713
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses48,610
Total Other Income/Expenses Net1,126-1,137
 

Technical Analysis of Stereotaxis
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Stereotaxis. The general trend of Stereotaxis is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Stereotaxis's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Stereotaxis Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 2.41 < 2.49 < 2.505.

The bearish price targets are: 2.03 > 1.82 > 1.82.

Tweet this
Stereotaxis Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Stereotaxis Inc. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Stereotaxis Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Stereotaxis Inc. The current macd is 0.04871994.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Stereotaxis price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Stereotaxis. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Stereotaxis price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Stereotaxis Inc Daily Moving Average Convergence/Divergence (MACD) ChartStereotaxis Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Stereotaxis Inc. The current adx is 23.08.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Stereotaxis shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Stereotaxis Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Stereotaxis Inc. The current sar is 2.13225956.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Stereotaxis Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Stereotaxis Inc. The current rsi is 55.78. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Stereotaxis Inc Daily Relative Strength Index (RSI) ChartStereotaxis Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Stereotaxis Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Stereotaxis price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Stereotaxis Inc Daily Stochastic Oscillator ChartStereotaxis Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Stereotaxis Inc. The current cci is 62.70.

Stereotaxis Inc Daily Commodity Channel Index (CCI) ChartStereotaxis Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Stereotaxis Inc. The current cmo is 12.44.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Stereotaxis Inc Daily Chande Momentum Oscillator (CMO) ChartStereotaxis Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Stereotaxis Inc. The current willr is -41.55124654.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Stereotaxis is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Stereotaxis Inc Daily Williams %R ChartStereotaxis Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Stereotaxis Inc.

Stereotaxis Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Stereotaxis Inc. The current atr is 0.13964913.

Stereotaxis Inc Daily Average True Range (ATR) ChartStereotaxis Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Stereotaxis Inc. The current obv is 6,229,856.

Stereotaxis Inc Daily On-Balance Volume (OBV) ChartStereotaxis Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Stereotaxis Inc. The current mfi is 60.01.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Stereotaxis Inc Daily Money Flow Index (MFI) ChartStereotaxis Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Stereotaxis Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-08-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-08-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-03ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-12-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-31CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Stereotaxis Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Stereotaxis Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.784
Ma 20Greater thanMa 502.288
Ma 50Greater thanMa 1002.149
Ma 100Greater thanMa 2002.103
OpenGreater thanClose2.330
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Stereotaxis with someone you think should read this too:
  • Are you bullish or bearish on Stereotaxis? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Stereotaxis? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Stereotaxis Inc

I send you an email if I find something interesting about Stereotaxis Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Stereotaxis Inc.

Receive notifications about Stereotaxis Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.